Skip to main content

Table 5 Number and percentage of eligible women who received SP1, SP2 and SP3 by LGA

From: Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria

 

Dange Shuni

Goronyo

Silame

Intervention combined

Yabo

Total

Pregnant women eligible for SP between April and November 2015

9136

10,850

5586

25,572

5921

31,493

Number of SPI doses consumed

7408

10,893

6013

24,314

1527

25,841

% Given SP1

81

100

108

95

26

82

Number of SP2 doses consumed

5334

7304

4656

17,294

767

18,061

% Given SP2

58

67

83

68

13

57

Number of SP3+ doses consumed

2922

5381

3128

11,431

0

11,431

% Given SP3+

32

50

56

45

0

36

Total number of doses SP doses given

15,664

23,578

13,797

53,039

2294

55,333

Mean doses of SP delivered to eligible women

1.71

2.17

2.47

2.07

0.39

1.76